(Q37157697)

18 August 2017

1 reference

title

Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives (English)

1 reference

18 August 2017

0 references

anti-retroviral agent

0 references

1 reference

Shareen Y El-Ibiary

1

1 reference

18 August 2017

Jennifer M Cocohoba

series ordinal

2

1 reference

18 August 2017

publication date

1 June 2008

1 reference

The European Journal of Contraception Reproductive Health Care

18 August 2017

published in

1 reference

18 August 2017

volume

13

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

123-132

1 reference

Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Pregnancies before and after HIV diagnosis in a european cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Oral contraception does not alter single dose saquinavir pharmacokinetics in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women: the importance of an event-level focus for promoting safer sexual behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13625180701829952

10.1080/13625180701829952

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference